148 related articles for article (PubMed ID: 38349844)
1. Evidence for C-Peptide as a Validated Surrogate to Predict Clinical Benefits in Trials of Disease-Modifying Therapies for Type 1 Diabetes.
Latres E; Greenbaum CJ; Oyaski ML; Dayan CM; Colhoun HM; Lachin JM; Skyler JS; Rickels MR; Ahmed ST; Dutta S; Herold KC; Marinac M
Diabetes; 2024 Jun; 73(6):823-833. PubMed ID: 38349844
[TBL] [Abstract][Full Text] [Related]
2. C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.
Palmer JP; Fleming GA; Greenbaum CJ; Herold KC; Jansa LD; Kolb H; Lachin JM; Polonsky KS; Pozzilli P; Skyler JS; Steffes MW
Diabetes; 2004 Jan; 53(1):250-64. PubMed ID: 14693724
[TBL] [Abstract][Full Text] [Related]
3. C-peptide antioxidant adaptive pathways in β cells and diabetes.
Luppi P; Drain P
J Intern Med; 2017 Jan; 281(1):7-24. PubMed ID: 27251308
[TBL] [Abstract][Full Text] [Related]
4. Metabolic factors affecting residual beta cell function assessed by C-peptide secretion in patients with newly diagnosed type 1 diabetes.
Picardi A; Visalli N; Lauria A; Suraci C; Buzzetti R; Merola MK; Manfrini S; Guglielmi C; Gentilucci UV; Pitocco D; Crinò A; Bizzarri C; Cappa M; Pozzilli P
Horm Metab Res; 2006 Oct; 38(10):668-72. PubMed ID: 17075776
[TBL] [Abstract][Full Text] [Related]
5. Pancreatic beta cell function persists in many patients with chronic type 1 diabetes, but is not dramatically improved by prolonged immunosuppression and euglycaemia from a beta cell allograft.
Liu EH; Digon BJ; Hirshberg B; Chang R; Wood BJ; Neeman Z; Kam A; Wesley RA; Polly SM; Hofmann RM; Rother KI; Harlan DM
Diabetologia; 2009 Jul; 52(7):1369-80. PubMed ID: 19418039
[TBL] [Abstract][Full Text] [Related]
6. Defining Outcomes for β-cell Replacement Therapy in the Treatment of Diabetes: A Consensus Report on the Igls Criteria From the IPITA/EPITA Opinion Leaders Workshop.
Rickels MR; Stock PG; de Koning EJP; Piemonti L; Pratschke J; Alejandro R; Bellin MD; Berney T; Choudhary P; Johnson PR; Kandaswamy R; Kay TWH; Keymeulen B; Kudva YC; Latres E; Langer RM; Lehmann R; Ludwig B; Markmann JF; Marinac M; Odorico JS; Pattou F; Senior PA; Shaw JAM; Vantyghem MC; White S
Transplantation; 2018 Sep; 102(9):1479-1486. PubMed ID: 29528967
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic β-Cell Function Is Associated with Augmented Counterregulation to In-Exercise Hypoglycemia in Type 1 Diabetes.
McCarthy O; Pitt J; Eckstein ML; Moser O; Bain SC; Bracken RM
Med Sci Sports Exerc; 2021 Jul; 53(7):1326-1333. PubMed ID: 34127632
[TBL] [Abstract][Full Text] [Related]
8. GLP-1 agonists in type 1 diabetes.
Pettus J; Hirsch I; Edelman S
Clin Immunol; 2013 Dec; 149(3):317-23. PubMed ID: 23643354
[TBL] [Abstract][Full Text] [Related]
9. Fall in C-Peptide During First 4 Years From Diagnosis of Type 1 Diabetes: Variable Relation to Age, HbA1c, and Insulin Dose.
Hao W; Gitelman S; DiMeglio LA; Boulware D; Greenbaum CJ;
Diabetes Care; 2016 Oct; 39(10):1664-70. PubMed ID: 27422577
[TBL] [Abstract][Full Text] [Related]
10. Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes.
Quattrin T; Haller MJ; Steck AK; Felner EI; Li Y; Xia Y; Leu JH; Zoka R; Hedrick JA; Rigby MR; Vercruysse F;
N Engl J Med; 2020 Nov; 383(21):2007-2017. PubMed ID: 33207093
[TBL] [Abstract][Full Text] [Related]
11. An improved clinical model to predict stimulated C-peptide in children with recent-onset type 1 diabetes.
Buchanan K; Mehdi AM; Hughes I; Cotterill A; Le Cao KA; Thomas R; Harris M
Pediatr Diabetes; 2019 Mar; 20(2):166-171. PubMed ID: 30556344
[TBL] [Abstract][Full Text] [Related]
12. [C-peptide residual secretion makes difference on type 1 diabetes management?].
Rodacki M; Milech A; Oliveira JE
Arq Bras Endocrinol Metabol; 2008 Mar; 52(2):322-33. PubMed ID: 18438543
[TBL] [Abstract][Full Text] [Related]
13. Islet autoimmunity identifies a unique pattern of impaired pancreatic beta-cell function, markedly reduced pancreatic beta cell mass and insulin resistance in clinically diagnosed type 2 diabetes.
Subauste A; Gianani R; Chang AM; Plunkett C; Pietropaolo SL; Zhang YJ; Barinas-Mitchell E; Kuller LH; Galecki A; Halter JB; Pietropaolo M
PLoS One; 2014; 9(9):e106537. PubMed ID: 25226365
[TBL] [Abstract][Full Text] [Related]
14. Use of technology to potentially preserve C-Peptide in type 1 diabetes mellitus.
Danne T; Kordonouri O
Pediatr Endocrinol Rev; 2010 Aug; 7 Suppl 3():396-400. PubMed ID: 20877252
[TBL] [Abstract][Full Text] [Related]
15. Proinsulin to C-Peptide Ratio in the First Year After Diagnosis of Type 1 Diabetes.
Freese J; Al-Rawi R; Choat H; Martin A; Lunsford A; Tse H; Mick G; McCormick K
J Clin Endocrinol Metab; 2021 Oct; 106(11):e4318-e4326. PubMed ID: 34228132
[TBL] [Abstract][Full Text] [Related]
16. Insulin secretion measured by stimulated C-peptide in long-established Type 1 diabetes in the Diabetes Control and Complications Trial (DCCT)/ Epidemiology of Diabetes Interventions and Complications (EDIC) cohort: a pilot study.
McGee P; Steffes M; Nowicki M; Bayless M; Gubitosi-Klug R; Cleary P; Lachin J; Palmer J;
Diabet Med; 2014 Oct; 31(10):1264-8. PubMed ID: 24836354
[TBL] [Abstract][Full Text] [Related]
17. Islet autotransplantation to preserve beta cell mass in selected patients with chronic pancreatitis and diabetes mellitus undergoing total pancreatectomy.
Bellin MD; Beilman GJ; Dunn TB; Pruett TL; Chinnakotla S; Wilhelm JJ; Ngo A; Radosevich DM; Freeman ML; Schwarzenberg SJ; Balamurugan AN; Hering BJ; Sutherland DE
Pancreas; 2013 Mar; 42(2):317-21. PubMed ID: 23146918
[TBL] [Abstract][Full Text] [Related]
18. Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation.
Brooks AM; Oram R; Home P; Steen N; Shaw JA
Diabetes Care; 2015 Jan; 38(1):105-12. PubMed ID: 25422169
[TBL] [Abstract][Full Text] [Related]
19. Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes.
Watkins RA; Evans-Molina C; Terrell JK; Day KH; Guindon L; Restrepo IA; Mirmira RG; Blum JS; DiMeglio LA
Transl Res; 2016 Feb; 168():96-106.e1. PubMed ID: 26397425
[TBL] [Abstract][Full Text] [Related]
20. Age-dependent decline of β-cell function in type 1 diabetes after diagnosis: a multi-centre longitudinal study.
Barker A; Lauria A; Schloot N; Hosszufalusi N; Ludvigsson J; Mathieu C; Mauricio D; Nordwall M; Van der Schueren B; Mandrup-Poulsen T; Scherbaum WA; Weets I; Gorus FK; Wareham N; Leslie RD; Pozzilli P
Diabetes Obes Metab; 2014 Mar; 16(3):262-7. PubMed ID: 24118704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
